{"id":"W2590921469","doi":"10.1200/jco.2014.32.30_suppl.265","title":"Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McGill University; Centre Hospitalier de l’Université de Montréal; University of Calgary; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Sorafenib; Renal cell carcinoma; Temsirolimus; Everolimus; Internal medicine; Oncology; Kidney cancer; Cohort; Urology; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004254775,0.0001693482,0.0003561637,0.002516825,0.000405842,0.0006091127,0.0009246683,0.0002614487,0.001663505],"category_scores_gemma":[0.01772065,0.0001300011,0.0006868718,0.005403053,0.0003550164,0.0005140295,0.0007490126,0.000745567,0.0002094257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00330082,"about_ca_system_score_gemma":0.003980126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1571837,"about_ca_topic_score_gemma":0.1019813,"domain_scores_codex":[0.9953775,0.0007203335,0.0008387703,0.0004735289,0.002171571,0.0004182706],"domain_scores_gemma":[0.963275,0.003617316,0.02416571,0.0007747054,0.005473792,0.002693561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003578702,0.0000127263,0.9954349,0.00006567154,0.00004522337,0.000008400859,0.00005042083,0.0000741701,0.00003856873,0.00002556166,0.001794835,0.002413633],"study_design_scores_gemma":[0.000005854619,0.00003437254,0.9983394,0.00003467637,0.00001981696,0.00006718044,0.0001187406,0.0003357006,0.00005845635,0.00002256936,0.0009571962,0.000005898557],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.927781,0.00344494,0.001318397,0.001594656,0.00008803945,0.0002967783,0.05972669,0.0001124753,0.005637065],"genre_scores_gemma":[0.9860926,0.0006559568,0.0005691154,0.0001410645,0.00002376526,0.0001065526,0.01220906,0.000007745462,0.0001940851],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1571837,"threshold_uncertainty_score":0.3125375,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1825192556823884,"score_gpt":0.4616830831802272,"score_spread":0.2791638274978387,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}